Next week, members of the Department of Radiation Oncology will attend the 59th annual meeting of the American Society for Radiation Oncology (ASTRO), the largest radiation oncology meeting in the United States, attracting national and international attendees from all areas of the field. This year’s conference will be held in San Diego, CA from September 24-27.
This year, the Washington University Department of Radiation Oncology will be represented by 16 oral presentations and 28 posters. Some members of the faculty will also serve as moderators or discussants for sessions. “ASTRO is the premier radiation oncology society in the world, with more than 10,000 members who are physicians, nurses, biologists, physicists, radiation therapists, dosimetrists and other professionals who specialize in treating patients with radiation therapies. We are proud that members of our department play such a prominent role in shaping the future of cancer care through scientific presentations and advocacy at our Society’s annual meeting,” says Jeff Michalski, MD, vice chairman of radiation oncology and the Carlos Perez Distinguished Professor of Radiation Oncology.
View the current schedule of WUSM Department of Radiation Oncology presentations at ASTRO »
Three faculty members have received awards or other recognition at this year’s meeting. Stephanie Markovina, MD, PhD, has been awarded a Basic/Translational Science Abstract Award for her presentation, Squamous Cell Carcinoma Antigen Mediates Radiation Resistance in Cervical Cancer, which details her findings that a protein that can signify aggressive disease in patients with cervical cancer may also be acting inside the tumor cell to protect it against radiation. Olga Green, PhD, received an Annual Meeting Travel Award for her abstract, MRI-directed EP-Guided Noninvasive Cardiac Radioablation (ENCORE) for Treatment of Ventricular Tachycardia (VT), which discusses recent work evaluating the feasibility of treating severe heart arrhythmia using a new magnetic resonance image-guided linear accelerator (MR-Linac) radiotherapy system. Dr. Jeffrey Bradley will also be recognized as a fellow of the society (read more).